Biogen reported $3.35B in Current Liabilities for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Acadia Pharmaceuticals ACAD:US $ 95.33M 14.04M
Alexion Pharmaceuticals ALXN:US $ 1426.2M 198.5M
ALKERMES ALKS:US $ 383.44M 17.6M
Amgen AMGN:US $ 14585M 1716M
Bayer BAYN:GR € 27926M 1006M
Biogen BIIB:US $ 3347.2M 181.4M
Biomarin Pharmaceutical BMRN:US $ 443.34M 13.31M
Bluebird Bio BLUE:US $ 247.76M 41.45M
Bristol Myers Squibb BMY:US $ 18991M 1661M
Eli Lilly And LLY:US $ 15093.2M 3379M
Esperion Therapeutics ESPR:US $ 82.64M 15.25M
Gilead Sciences GILD:US $ 10214M 509M
Gw Pharmaceuticals GWPH:US $ 160.25M 0.44M
Intercept Pharmaceuticals ICPT:US $ 145.28M 0.95M
Intra Cellular Therapies ITCI:US $ 50.42M 10.72M
Marinus Pharmaceuticals MRNS:US $ 16.69M 0.57M
Moderna Inc MRNA:US 8.84B 399M
Neurocrine Biosciences NBIX:US $ 212.9M 22.9M
Novartis NOVN:VX SF 29633M 527M
Ptc Therapeutics PTCT:US $ 290.96M 40.01M
Puma Biotechnology PBYI:US $ 137.9M 2.51M
Regeneron Pharmaceuticals REGN:US $ 3732.4M 514.6M
Sangamo Biosciences SGMO:US $ 136.94M 4.1M
Sarepta Therapeutics SRPT:US $ 425.02M 60.29M
Seattle Genetics SGEN:US $ 433.83M 44.22M
Teva Pharmaceutical TEVA:IT 12.69B 602M
Ultragenyx Pharmaceutical RARE:US $ 127.07M 0.02M
United Therapeutics UTHR:US $ 311.4M 9M
Vertex Pharmaceuticals VRTX:US $ 1836.45M 107.6M
YTE INCY:US $ 660.32M 36.44M